株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

動物用医薬品の世界市場:機会と戦略 (2030年まで) - 医薬品の種類別 (駆虫剤、ワクチン、抗生物質など)・動物の種類別・投与経路別 (経口薬など)・エンドユース別

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030; By Type Of Pharmaceutical: Veterinary Parasiticides/Vaccines; Others - Veterinary Pharmaceuticals/Antibiotics; Animal Type; Route of Administration: Oral; Others; End-Use

発行 The Business Research Company 商品コード 918124
出版日 ページ情報 英文 486 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.19円で換算しております。
Back to Top
動物用医薬品の世界市場:機会と戦略 (2030年まで) - 医薬品の種類別 (駆虫剤、ワクチン、抗生物質など)・動物の種類別・投与経路別 (経口薬など)・エンドユース別 Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030; By Type Of Pharmaceutical: Veterinary Parasiticides/Vaccines; Others - Veterinary Pharmaceuticals/Antibiotics; Animal Type; Route of Administration: Oral; Others; End-Use
出版日: 2020年01月07日 ページ情報: 英文 486 Pages
概要

当レポートでは、世界の動物用医薬品の市場について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し (過去5年間・今後10年間分)、分野別・地域別・主要国の詳細動向、主なマクロ経済指標・関連産業指標との対比、主要企業のプロファイル、近年の主な企業合併・買収 (M&A)、関連市場の構造・動向などを調査しております。

第1章 エグゼクティブ・サマリー:ドライクリーニング/ランドリーサービス

第2章 目次

第3章 図の一覧

第4章 表の一覧

第5章 分析構造

第6章 イントロダクション

第7章 市場の特徴:動物用医薬品

  • 市場の定義
  • 市場区分:製品の種類別
    • 動物用ワクチン
    • 動物用抗生物質
    • 動物用駆虫剤
    • その他
  • 市場区分:エンドユーザー別
    • 動物病院
    • 動物クリニック
    • 薬局・ドラッグストア
  • 市場区分:投与経路 (RoA) 別
    • 経口薬
    • その他
  • 市場区分:動物の種類別
    • 家畜
    • ペット (コンパニオンアニマル)
  • 市場区分:ワクチンの種類別
    • 不活化ワクチン
    • 弱毒化ワクチン
    • 遺伝子組み換えワクチン
    • その他
  • 市場区分:抗生物質の種類別
    • テトラサイクリン
    • ペニシリン
    • スルホンアミド
    • マクロライド
    • アミノグリコサイド
    • その他

第8章 動物用医薬品市場:サプライチェーンの分析

  • サプライチェーン
    • 原材料サプライヤー
    • CRO (医薬品開発業務受託機関)
    • 動物用医薬品メーカー
    • CMO (医薬品製造受託機関)
    • 卸売業者/流通業者
    • 小売業者 (動物用薬局など)・動物病院
    • エンドユーザー

第9章 動物用医薬品市場:製品分析 - 製品事例

第10章 動物用医薬品市場:顧客情報

  • オピオイド剤の不足から、効能の低い薬剤を治療に用いる獣医が多い
  • 米国の獣医は、イヌにマリファナを治療目的で与えることに消極的である
  • 米国のペット所有者:この数年で3倍に増加
  • ネコ用・イヌ用治療薬の大半は、現在でも動物病院で販売されている
  • ペット保険:米国での加入率は非常に低い
  • ペットの肥満:未だに重大な課題
  • 「人間と動物のつながり」の利点に関する科学研究について知識が増えるにつれ、飼い主はペットの健康に気を遣うようになる
    • イヌ・ネコの飼い主の多くが、ペットの治療費に対する懸念を抱いている

第11章 動物用医薬品市場の動向と戦略

  • 技術開発促進のための戦略的な事業協力・提携
  • 「噛める錠剤」の開発
  • 動物用ジェネリック医薬品の開発
  • 抗生物質耐性に対処するためのナノテクノロジーの活用
  • ネコ向け・高血圧治療用の経口溶液
  • サブユニットワクチンやVLP (ウイルス様粒子) ワクチンの活用
  • 免疫療法の活用

第12章 世界の動物用医薬品市場:規制環境

  • 動物用医薬品産業に別個の規制を課す必要性
  • 現在の規制シナリオ:米国、欧州、インド、ブラジル、オーストラリア・ニュージーランド、アフリカ
  • 地域間の規制の違い
  • 世界各国の規制の調和に向けた取り組み
  • 動物用医薬品向け規制:近年の改正の動き

第13章 動物用サービスの動物用医薬品市場に対する影響力

  • 国別分析 (米国、日本、中国、英国、ドイツ)

第14章 動物用医薬品:市場規模・成長率

  • 市場規模の実績値・予測値 (金額ベース)
    • 現在の市場促進要因
      • 新興国市場の成長
      • ペット向け支出額の増加
      • 疾患予防への取り組み強化
    • 現在の市場抑制要因
      • 獣医の不足
    • 将来的な市場促進要因
      • 経済成長
      • ペット保険の普及
    • 将来的な市場抑制要因

第15章 世界の動物用医薬品市場:市場区分

  • 市場規模:医薬品の種類別 (金額ベース、実績値・予測値)
  • 市場規模:動物の種類別 (金額ベース、実績値・予測値)
  • 市場規模:投与経路別 (金額ベース、実績値・予測値)
  • 市場規模:エンドユース別 (金額ベース、実績値・予測値)

第16章 世界の動物用医薬品市場の内訳

  • 市場規模:ワクチンの種類別 (金額ベース、実績値・予測値)
  • 市場規模:抗生物質の種類別 (金額ベース、実績値・予測値)

第17章 世界の動物用医薬品市場:地域別・国別分析

  • 市場規模:地域別 (金額ベース、実績値・予測値)
  • 市場規模:国別 (金額ベース、実績値・予測値)

第18章 アジア太平洋地域の動物用医薬品市場

  • 市場概要
    • 背景事情、政府の支援策・補助金制度、規制体制、税制、主要企業、近年の投資動向など
  • 市場規模 (金額ベース、実績値・予測値)
  • 市場規模:医薬品の種類別 (実績値・予測値)
  • 市場規模:動物の種類別 (実績値・予測値)
  • 市場規模:エンドユース別 (実績値・予測値)
  • 市場規模:抗生物質の種類別 (実績値・予測値)
  • 国別分析
  • 中国市場
    • 市場概要
    • 市場規模 (金額ベース、通算9年間分)
    • 市場規模:医薬品別/動物別/エンドユース別/抗生物質別 (金額ベース、通算9年間分)
  • インド市場
  • 日本市場
  • オーストラリア市場
  • インドネシア市場
  • 韓国市場

第19章 西欧の動物用医薬品市場

  • 英国市場
  • ドイツ市場
  • フランス市場

第20章 東欧の動物用医薬品市場

  • ロシア市場

第21章 北米の動物用医薬品市場

  • 米国市場

第22章 南米の動物用医薬品市場

  • ブラジル市場

第23章 中東の動物用医薬品市場

第24章 アフリカの動物用医薬品市場

第25章 市場競争環境:世界の動物用医薬品市場

  • 企業プロファイル
  • Zoetis Inc.
    • 企業概要
    • 主要製品・サービス
    • 事業戦略
    • 主な財務指標
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Inc.
  • Bayer AG

第26章 主な企業合併・買収 (M&A) の動き:動物用医薬品市場の場合

第27章 市場の背景事情:動物用医薬品

  • 市場の特徴:動物用医薬品市場
    • 市場の定義
    • 主な市場区分
  • 動物用医薬品市場:市場規模、産業別 (金額ベース、通算9年間分)
  • 動物用医薬品市場:市場規模、地域別 (金額ベース)
  • 動物用医薬品市場:市場規模、実績値・予測値 (金額ベース、通算9年間分)

第28章 世界のドライクリーニング/ランドリーサービス市場:機会と戦略

  • 新たな市場機会:国別
  • 新たな市場機会:分野別
  • 市場成長戦略
    • 市場動向に基づく戦略
    • 各企業の戦略

第29章 結論と提言

  • 結論
  • 提言
    • 製品・立地・価格・販促活動・人材など

第30章 付録

目次

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market.

Where is the largest and fastest growing market for the veterinary pharmaceuticals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global veterinary pharmaceutical market report to 2030 from the Business Research Company answers all these questions and many more.

The report covers the following chapters:

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by type.
  • Market Characteristics - The market characteristics section of the report defines and explains the veterinary pharmaceuticals market. This chapter includes different goods covered in the report and basic definitions.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the veterinary pharmaceuticals industry supply chain.
  • Product Analysis - The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  • Customer Information - This chapters covers recent customers' trends/preferences in the global veterinary pharmaceuticals market.
  • Trends And Strategies - This chapter describes the major trends shaping the global veterinary pharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Regulatory Landscape - This section describes the current regulatory scenario, the regional disparities in regulations, global regulation harmonization initiatives, and recent updates on veterinary pharmaceutical regulations.
  • Impact Of Veterinary Services On The Veterinary Pharmaceuticals Market - This chapter describes the impact of veterinary services on the veterinary pharmaceuticals market, and comparison between the veterinary services, veterinary medical equipment and veterinary pharmaceuticals markets across major countries.
  • Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2023, 2025 and 2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Market Segmentation - This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments and sub-segments in the market.
  • Regional And Country Analysis - This section contains the historic (2015-2019), forecast (2023, 2025 and 2030) market value and growth and market share comparison by region and countries.
  • Regional Market Size And Growth - This section contains the region's market size (2019), historic and forecast (2015-2019, 2023, 2025 and 2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape - This section covers details on the competitive landscape of the global veterinary pharmaceuticals market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background - This section describes the animal medicine market of which the veterinary pharmaceuticals market is a segment. This chapter includes the animal medicine market 2015-23 values, and regional analyses for the animal medicine market.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
1

Markets Covered

  • By Type Of Pharmaceutical: Veterinary Parasiticides; Veterinary Vaccines; Others - Veterinary Pharmaceuticals; Veterinary Antibiotics
  • By Animal Type: Livestock; Companion Animal
  • By Route of Administration: Oral; Others
  • By End-Use: Veterinary Hospitals; Pharmacies And Drug Stores; Veterinary Clinics
  • Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Elanco Animal Health Inc.; Bayer AG
  • Countries: China, India, Japan, Australia, South Korea, Indonesia, USA, Brazil, UK, Germany, France, Russia
  • Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time series: Five years historic and forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Veterinary Pharmaceuticals Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. By Type Of Pharmaceutical
    • 6.1.3. Segmentation By Animal Type
    • 6.1.4. Segmentation By Route of Administration
    • 6.1.5. Segmentation By End Use Channel

7. Veterinary Pharmaceuticals Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Type Of Product
    • 7.2.1. Veterinary Vaccines
    • 7.2.2. Veterinary Antibiotics
    • 7.2.3. Veterinary Parasiticides
    • 7.2.4. Others - Veterinary Pharmaceuticals
  • 7.3. Market Segmentation By End User
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
    • 7.3.3. Pharmacies And Drug Stores
  • 7.4. Market Segmentation By Route Of Administration
    • 7.4.1. Oral
    • 7.4.2. Others
  • 7.5. Market Segmentation By Type Of Animal
    • 7.5.1. Livestock
    • 7.5.2. Companion Animals
  • 7.6. Market Segmentation By Vaccines
    • 7.6.1. Inactivated Vaccines
    • 7.6.2. Attenuated Vaccines
    • 7.6.3. Recombinant Vaccines
    • 7.6.4. Others
  • 7.7. Market Segmentation By Antibiotics
    • 7.7.1. Tetracyclines
    • 7.7.2. Penicillins
    • 7.7.3. Sulphonamides
    • 7.7.4. Macrolides
    • 7.7.5. Aminoglycosides
    • 7.7.6. Others

8. Veterinary Pharmaceuticals Market, Supply Chain Analysis

    • 8.1.1. Raw Material Suppliers
    • 8.1.2. Contract Research Organization (CRO)
    • 8.1.3. Veterinary Pharmaceutical Manufacturer
    • 8.1.4. Contract Manufacturing Organization (CMO)
    • 8.1.5. Wholesalers/Distributors
    • 8.1.6. Retailers (Pharmacies And Veterinary Shops) And Veterinary Clinics
    • 8.1.7. End-Users

9. Veterinary Pharmaceuticals Market, Product Analysis -Product Examples

10. Veterinary Pharmaceuticals Market Customer Information

    • 10.1.1. Opioids Shortages Compel Veterinarians To Use Less Effective Drugs As Therapeutic Choices
    • 10.1.2. U.S. Veterinarians Are Reluctant To Discuss The Therapeutic Use Of Marijuana In Dogs
    • 10.1.3. Pet Ownership In The USA Has Tripled Over The Past Few Years
    • 10.1.4. Cat And Dog Medications Are Still Sold Mainly In Veterinary Clinics
    • 10.1.5. Pet Insurance Penetration In The USA Is Very Low
    • 10.1.6. Pet Obesity Remains A Big Issue
    • 10.1.7. The More Pet Owners Learn About Scientific Research On The Benefits Of The Human-Animal Bond, The More Likely They Are To Take Actions To Improve Pet Health.
    • 10.1.8. Dog And Cat Owners Alike Are Concerned About The Cost Of Medical Treatments For Their Pets

11. Veterinary Pharmaceuticals Market Trends And Strategies

  • 11.1. Strategic Collaborations And Partnerships To Drive Innovations
  • 11.2. Development Of Chewable Tablets
  • 11.3. Production Of Generic Drugs For Animal Care
  • 11.4. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
  • 11.5. Oral Drug Solutions For The Treatment Of Feline Hypertension
  • 11.6. Use of Subunit And Virus-Like Particle (VLP)-Based Vaccines
  • 11.7. Use Of Immunotherapy

12. Global Veterinary Pharmaceuticals Market Regulatory Landscape

  • 12.1. Need For Separate Regulation For The Veterinary Pharmaceuticals Industry
  • 12.2. Current Regulatory Scenario
    • 12.2.1. USA
    • 12.2.2. Europe
    • 12.2.3. India
    • 12.2.4. Brazil
    • 12.2.5. Australia and New Zealand
    • 12.2.6. Africa
  • 12.3. Regional Disparities In Regulations
    • 12.3.1. Lack Of Regulatory Guidance
    • 12.3.2. Variations In Veterinary Pharmaceuticals Development Processes
    • 12.3.3. Variations In Safety Considerations For Veterinary Pharmaceuticals
    • 12.3.4. Differences In Registration Procedures
  • 12.4. Global Regulation Harmonization Initiatives
  • 12.5. Recent Updates On Veterinary Pharmaceutical Regulations

13. Impact Of Veterinary Services On The Veterinary Pharmaceuticals Market

    • 13.1.1. USA
    • 13.1.2. Japan
    • 13.1.3. China
    • 13.1.4. UK
    • 13.1.5. Germany

14. Global Veterinary Pharmaceuticals Market Size And Growth

  • 14.1. Historic And Forecast Market Growth, Value ($ Million)
    • 14.1.1. Drivers Of The Market 2015-2019
    • 14.1.2. Emerging Markets Growth
    • 14.1.3. Increased Pet Spending
    • 14.1.4. Increased Disease Prevalence
    • 14.1.5. Restraints On The Market 2015-2019
    • 14.1.6. Shortages Of Veterinarians
    • 14.1.7. Drivers Of The Market 2019-2023
    • 14.1.8. Economic Growth
    • 14.1.9. Increasing Penetration Of Pet Insurance
    • 14.1.10. Restraints On The Market 2019-2023

15. Global Veterinary Pharmaceuticals Market Segmentation

  • 15.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.4. Global Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

16. Global Veterinary Pharmaceuticals Market Sub-Segmentation

  • 16.1. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.2. Global Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

17. Veterinary Pharmaceuticals Market, Regional And Country Analysis

  • 17.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Asia-Pacific Veterinary Pharmaceuticals Market

  • 18.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Background Information
    • 18.1.4. Government Initiatives
    • 18.1.5. Regulatory Bodies
    • 18.1.6. Regulations
    • 18.1.7. Corporate Tax Structure
    • 18.1.8. Associations
    • 18.1.9. Tax Levied
    • 18.1.10. Investments
    • 18.1.11. Major Companies
  • 18.2. Asia-Pacific Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.6. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.7. Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
  • 18.8. China Veterinary Pharmaceuticals Market
  • 18.9. China Veterinary Pharmaceuticals Market Overview
    • 18.9.1. Country Information
    • 18.9.2. Market Information
    • 18.9.3. Background Information
    • 18.9.4. Regulatory Bodies
    • 18.9.5. Regulations
    • 18.9.6. Corporate Tax Structure
    • 18.9.7. Associations
    • 18.9.8. Tax Levied
    • 18.9.9. Investments
    • 18.9.10. Major Companies
  • 18.10. China Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.11. China Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.12. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.13. China Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.14. China Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.15. India Veterinary Pharmaceuticals Market
  • 18.16. India Veterinary Pharmaceuticals Market Overview
    • 18.16.1. Country Information
    • 18.16.2. Market Information
    • 18.16.3. Background Information
    • 18.16.4. Government Initiatives
    • 18.16.5. Regulatory Bodies
    • 18.16.6. Regulations
    • 18.16.7. Corporate Tax Structure
    • 18.16.8. Associations
    • 18.16.9. Tax Levied
    • 18.16.10. Investments
    • 18.16.11. Major Companies
  • 18.17. India Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.18. India Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.19. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.20. India Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.21. India Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.22. Japan Veterinary Pharmaceuticals Market
  • 18.23. Japan Veterinary Pharmaceuticals Market Overview
    • 18.23.1. Country Information
    • 18.23.2. Market Information
    • 18.23.3. Background Information
    • 18.23.4. Government Initiatives
    • 18.23.5. Regulatory Bodies
    • 18.23.6. Regulations
    • 18.23.7. Corporate Tax Structure
    • 18.23.8. Associations
    • 18.23.9. Tax Levied
    • 18.23.10. Investments
    • 18.23.11. Major Companies
  • 18.24. Japan Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.25. Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.26. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.27. Japan Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.28. Japan Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.29. Australia Veterinary Pharmaceuticals Market
  • 18.30. Australia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.31. Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.32. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.33. Australia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.34. Australia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.35. Indonesia Veterinary Pharmaceuticals Market
  • 18.36. Indonesia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.37. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.38. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.39. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.40. Indonesia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.41. South Korea Veterinary Pharmaceuticals Market
  • 18.42. South Korea Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.43. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.44. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.45. South Korea Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.46. South Korea Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Western Europe Veterinary Pharmaceuticals Market

  • 19.1. Western Europe Veterinary Pharmaceuticals Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulatory Bodies
    • 19.1.6. Regulations
    • 19.1.7. Corporate Tax Structure
    • 19.1.8. Associations
    • 19.1.9. Investments
    • 19.1.10. Major Companies
  • 19.2. Western Europe Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 19.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.6. Western Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.7. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
  • 19.8. UK Veterinary Pharmaceuticals Market
  • 19.9. UK Veterinary Pharmaceuticals Market Overview
    • 19.9.1. Country Information
    • 19.9.2. Market Information
    • 19.9.3. Background Information
    • 19.9.4. Government Initiatives
    • 19.9.5. Regulatory Bodies
    • 19.9.6. Regulations
    • 19.9.7. Corporate Tax Structure
    • 19.9.8. Associations
    • 19.9.9. Investments
    • 19.9.10. Major Companies
  • 19.10. UK Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 19.11. UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.12. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.13. UK Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.14. UK Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.15. Germany Veterinary Pharmaceuticals Market
  • 19.16. Germany Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 19.17. Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.18. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.19. Germany Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.20. Germany Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.21. France Veterinary Pharmaceuticals Market
  • 19.22. France Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 19.23. France Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.24. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.25. France Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.26. France Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Eastern Europe Veterinary Pharmaceuticals Market

  • 20.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Background Information
    • 20.1.4. Regulatory Bodies
    • 20.1.5. Regulations
    • 20.1.6. Corporate Tax Structure
    • 20.1.7. Associations
    • 20.1.8. Tax Levied
    • 20.1.9. Investment
    • 20.1.10. Major Companies
  • 20.2. Eastern Europe Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 20.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.6. Eastern Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.7. Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis
  • 20.8. Russia Veterinary Pharmaceuticals Market
  • 20.9. Russia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 20.10. Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.12. Russia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.13. Russia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

21. North America Veterinary Pharmaceuticals Market

  • 21.1. North America Veterinary Pharmaceuticals Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. Background Information
    • 21.1.4. Government Initiatives
    • 21.1.5. Regulatory Bodies
    • 21.1.6. Regulations
    • 21.1.7. Corporate Tax Structure
    • 21.1.8. Associations
    • 21.1.9. Tax Levied
    • 21.1.10. Investments
    • 21.1.11. Major Companies
  • 21.2. North America Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 21.3. North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.4. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.5. North America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.6. North America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.7. North America Veterinary Pharmaceuticals Market: Country Analysis
  • 21.8. USA Veterinary Pharmaceuticals Market
  • 21.9. USA Veterinary Pharmaceuticals Market Overview
    • 21.9.1. Region Information
    • 21.9.2. Market Information
    • 21.9.3. Background Information
    • 21.9.4. Government Initiatives
    • 21.9.5. Regulatory Bodies
    • 21.9.6. Regulations
    • 21.9.7. Corporate Tax Structure
    • 21.9.8. Associations
    • 21.9.9. Tax Levied
    • 21.9.10. Investments
    • 21.9.11. Major Companies
  • 21.10. USA Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 21.11. USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.12. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.13. USA Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.14. USA Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

22. South America Veterinary Pharmaceuticals Market

  • 22.1. South America Veterinary Pharmaceuticals Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Background Information
    • 22.1.4. Regulatory Bodies
    • 22.1.5. Regulations
    • 22.1.6. Corporate Tax Structure
    • 22.1.7. Associations
    • 22.1.8. Tax Levied
    • 22.1.9. Investments
    • 22.1.10. Major Companies
  • 22.2. South America Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 22.3. South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.4. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.5. South America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.6. South America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.7. South America Veterinary Pharmaceuticals Market: Country Analysis
  • 22.8. Brazil Veterinary Pharmaceuticals Market
  • 22.9. Brazil Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 22.10. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.13. Brazil Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

23. Middle East Veterinary Pharmaceuticals Market

  • 23.1. Middle East Veterinary Pharmaceuticals Market Overview
    • 23.1.1. Region Overview
    • 23.1.2. Market Information
    • 23.1.3. Background Information
    • 23.1.4. Regulatory Bodies
    • 23.1.5. Regulations
    • 23.1.6. Corporate Tax Structure
    • 23.1.7. Associations
    • 23.1.8. Major Companies
  • 23.2. Middle East Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 23.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.6. Middle East Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

24. Africa Veterinary Pharmaceuticals Market

  • 24.1. Africa Veterinary Pharmaceuticals Market Overview
    • 24.1.1. Region Information
    • 24.1.2. Market Information
    • 24.1.3. Background Information
    • 24.1.4. Regulatory Bodies
    • 24.1.5. Regulations
    • 24.1.6. Corporate Tax Structure
    • 24.1.7. Associations
    • 24.1.8. Investments
    • 24.1.9. Major Companies
  • 24.2. Africa Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 24.3. Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.5. Africa Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.6. Africa Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

25. Global Veterinary Pharmaceuticals Market Competitive Landscape

  • 25.1. Company Profiles
  • 25.2. Zoetis Inc.
    • 25.2.1. Company Overview
    • 25.2.2. Products And Services
    • 25.2.3. Business Strategy
    • 25.2.4. Financial Overview
  • 25.3. Boehringer Ingelheim International GmbH
    • 25.3.1. Company Overview
    • 25.3.2. Products And Services
    • 25.3.3. Business Strategy
    • 25.3.4. Financial Overview
  • 25.4. Merck & Co., Inc.
    • 25.4.1. Company Overview
    • 25.4.2. Products And Services
    • 25.4.3. Business Strategy
    • 25.4.4. Financial Overview
  • 25.5. Elanco Animal Health Inc.
    • 25.5.1. Company Overview
    • 25.5.2. Products And Services
    • 25.5.3. Business Strategy
    • 25.5.4. Financial Overview
  • 25.6. Bayer AG
    • 25.6.1. Company Overview
    • 25.6.2. Products And Services
    • 25.6.3. Business Strategy
    • 25.6.4. Financial overview

26. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

  • 26.1. Elanco Animal Health Acquired Bayer's AG
  • 26.2. Merck Animal Health Acquired Antelliq Corporation
  • 26.3. Henry Schein Animal Health Merges With Vets First Choice
  • 26.4. Mars Petcare Acquired AniCura
  • 26.5. PHARMAQ Collaborated With Vinh Hoan
  • 26.6. Animal Health Division Of Merck & Co. Collaborated With Vinovo
  • 26.7. Wageningen Bioveterinary Research Collaborated With Ceva
  • 26.8. Animalcare Group Acquired Ecuphar
  • 26.9. Merck Animal Health Acquired Vallee S.A.
  • 26.10. Elanco Animal Health Acquired Boehringer Ingelheim Vetmedica's Vaccine Portfolio
  • 26.11. Ceva Acquired Portfolio Of Merial Swine And Cattle Vaccines
  • 26.12. Dechra Holdings US (A U.S Subsidiary of Dechra Pharmaceuticals PLC Acquired Putney Inc.
  • 26.13. Zydus Cadila Acquired Zoetis
  • 26.14. Eli Lilly And Company Acquired Novartis Animal Health

27. Market Background: Animal Medicine

  • 27.1. Animal Medicine Market Characteristics
    • 27.1.1. Market Definition
    • 27.1.2. Segmentation Type Of Medicine
  • 27.2. Global Animal Medicine Market, Segmentation By Industry, 2015 - 2023, Value ($ Million)
  • 27.3. Global Animal Medicine Market, 2019, By Region, Value ($ Million)
  • 27.4. Global Animal Medicine Market, 2015 - 2023, Historic And Forecast, By Region

28. Global Veterinary Pharmaceuticals Market Opportunities And Strategies

  • 28.1. Global Veterinary Pharmaceuticals Market In 2023 - Countries Offering Most New Opportunities
  • 28.2. Global Veterinary Pharmaceuticals Market In 2023 - Segments Offering Most New Opportunities
  • 28.3. Global Veterinary Pharmaceuticals Market In 2023 - Growth Strategies
    • 28.3.1. Market Trend Based Strategies
    • 28.3.2. Competitor Strategies

29. Veterinary Pharmaceuticals Market, Conclusions And Recommendations

  • 29.1. Conclusions
  • 29.2. Recommendations
    • 29.2.1. Product
    • 29.2.2. Place
    • 29.2.3. Price
    • 29.2.4. Promotion
    • 29.2.5. People

30. Appendix

  • 30.1. Market Data Sources
  • 30.2. Research Methodology
  • 30.3. Currencies
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright and Disclaimer
Back to Top